JP2016519138A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519138A5 JP2016519138A5 JP2016512345A JP2016512345A JP2016519138A5 JP 2016519138 A5 JP2016519138 A5 JP 2016519138A5 JP 2016512345 A JP2016512345 A JP 2016512345A JP 2016512345 A JP2016512345 A JP 2016512345A JP 2016519138 A5 JP2016519138 A5 JP 2016519138A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- protein
- tafa4
- seq
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305592.1 | 2013-05-06 | ||
| EP13305592.1A EP2801369A1 (en) | 2013-05-06 | 2013-05-06 | TAFA4 compounds and uses thereof for treating pain |
| PCT/EP2014/059247 WO2014180853A1 (en) | 2013-05-06 | 2014-05-06 | Tafa4 compounds and uses thereof for treating pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016519138A JP2016519138A (ja) | 2016-06-30 |
| JP2016519138A5 true JP2016519138A5 (https=) | 2018-08-30 |
| JP6487419B2 JP6487419B2 (ja) | 2019-03-20 |
Family
ID=48428409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016512345A Active JP6487419B2 (ja) | 2013-05-06 | 2014-05-06 | Ｔａｆａ４化合物及び疼痛を処置するためのその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9884088B2 (https=) |
| EP (2) | EP2801369A1 (https=) |
| JP (1) | JP6487419B2 (https=) |
| CN (1) | CN105209056B (https=) |
| CA (2) | CA2910652C (https=) |
| DK (1) | DK2994157T3 (https=) |
| ES (1) | ES2813629T3 (https=) |
| WO (1) | WO2014180853A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107430121B (zh) * | 2015-03-13 | 2020-06-23 | 希森美康株式会社 | 受试物质的检测方法及在该方法中使用的试剂盒 |
| EP3703558A4 (en) * | 2017-10-30 | 2021-08-11 | The Regents of The University of California | CALIBRATION-FREE IN-VIVO MEASUREMENT OF ANALYTES USING ELECTROCHEMICAL SENSORS |
| CA3097999A1 (en) | 2018-04-24 | 2019-10-31 | Neuracle Science Co., Ltd. | Use of anti-family with sequence similarity 19, member a5 antibodies for the treatment of neuropathic pain |
| EP3856228B1 (en) * | 2018-09-27 | 2023-03-08 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Tafa4 polypeptide for use for reducing skin inflammation |
| CN109596818B (zh) * | 2018-12-13 | 2024-03-19 | 丁蓉 | 一种基于电生理学分析当归四逆汤预防奥沙利铂神经毒性机制的研究方法 |
| JP2023511762A (ja) * | 2020-02-04 | 2023-03-22 | インサーム（インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル） | 炎症性疾患の処置のための方法及び医薬組成物 |
| CA3167629A1 (en) * | 2020-02-13 | 2021-08-19 | Alexander Theodore CHESLER | Margaric acid decreases piez02-mediated pain |
| CA3239578A1 (en) | 2021-12-17 | 2023-06-22 | Stephane GAILLARD | Peptides and methods for use in treating pain |
| WO2023122436A2 (en) * | 2021-12-20 | 2023-06-29 | Amgen Inc. | Dll3 binding peptides and uses thereof |
| EP4499163A1 (en) * | 2022-03-24 | 2025-02-05 | Baxter International Inc. | Dialysis system having thermoelectric heating |
| AR129441A1 (es) | 2022-05-25 | 2024-08-28 | Tafalgie Therapeutics | Péptidos y métodos para el tratamiento del dolor |
| JP2025520099A (ja) * | 2022-05-31 | 2025-07-01 | ニューラクル ジェネティクス インコーポレイテッド | 網膜又は黄斑疾患治療用組成物 |
| JP2026509101A (ja) | 2023-02-17 | 2026-03-17 | ナオス・インスティテュート・オブ・ライフ・サイエンス | 皮膚耐性閾値を増加させることが可能な生態生物学的化合物の選択のための方法 |
| WO2025116606A1 (ko) * | 2023-11-30 | 2025-06-05 | 주식회사 뉴라클제네틱스 | 신규한 케모카인-유사 단백질 단편 |
| CN121249875B (zh) * | 2025-10-13 | 2026-03-20 | 上海交通大学医学院附属仁济医院 | 外周神经系统中的Mas相关G蛋白耦联受体D在缓解阿片类药物耐受中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090077680A1 (en) * | 2000-06-12 | 2009-03-19 | Alejandro Abuin | Genetically Engineered and Photyped Mice and Stem Cell Clones for Producing the Same |
| WO2006013462A2 (en) * | 2004-07-30 | 2006-02-09 | Nsgene A/S | Growth factors nsg28, nsg30, and nsg32 |
-
2013
- 2013-05-06 EP EP13305592.1A patent/EP2801369A1/en not_active Withdrawn
-
2014
- 2014-05-06 EP EP14723045.2A patent/EP2994157B1/en active Active
- 2014-05-06 JP JP2016512345A patent/JP6487419B2/ja active Active
- 2014-05-06 CA CA2910652A patent/CA2910652C/en active Active
- 2014-05-06 ES ES14723045T patent/ES2813629T3/es active Active
- 2014-05-06 WO PCT/EP2014/059247 patent/WO2014180853A1/en not_active Ceased
- 2014-05-06 DK DK14723045.2T patent/DK2994157T3/da active
- 2014-05-06 CN CN201480025716.5A patent/CN105209056B/zh active Active
- 2014-05-06 CA CA3235916A patent/CA3235916A1/en active Pending
- 2014-05-06 US US14/787,483 patent/US9884088B2/en active Active
-
2017
- 2017-12-14 US US15/841,342 patent/US20180110829A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016519138A5 (https=) | ||
| JP7379428B2 (ja) | Ｎｋ細胞におけるサイトカイン誘導性ｓｈ２タンパク質の阻害 | |
| EP3371207B1 (en) | Nucleic acids, peptides and methods | |
| Park et al. | Molecular cloning and functional analysis of nucleotide-binding oligomerization domain 1 (NOD1) in olive flounder, Paralichthys olivaceus | |
| Rothenburg et al. | Double-stranded RNA-activated protein kinase PKR of fishes and amphibians: varying the number of double-stranded RNA binding domains and lineage-specific duplications | |
| US20160025745A1 (en) | Methods of diagnosing and treating fibrosis | |
| JP2019500414A5 (https=) | ||
| JP2017213006A5 (https=) | ||
| Schnöder et al. | Neuronal deficiency of p38α-MAPK ameliorates symptoms and pathology of APP or tau-transgenic Alzheimer's mouse models | |
| JP2015522264A5 (https=) | ||
| US11931402B2 (en) | Compositions for treating heart disease by inhibiting the action of mAKAP-β | |
| JP2017533910A5 (https=) | ||
| EP3658157A1 (en) | Treatment of heart disease by inhibition of the action of muscle a-kinase anchoring protein (makap) | |
| US20100266579A1 (en) | Treatment of inflammatory diseases | |
| US12258627B2 (en) | Kelch domain containing 7B (KLHDC7B) variants and uses thereof | |
| US20060154886A1 (en) | Regulatory elements in the 5' region of the VR1 gene | |
| JP5793188B2 (ja) | 自己免疫疾患治療及び予防薬としてのｃｔｒｐ６ | |
| Xiao et al. | Cloning of common carp SOCS-3 gene and its expression during embryogenesis, GH-transgene and viral infection | |
| Oliveira Filho et al. | Cloning, sequencing and expression analysis of the equine hepcidin gene by real-time PCR | |
| JP2016520570A (ja) | Ａ型インフルエンザウイルス感染の治療又は予防に使用するためのｐａｒ−４アンタゴニスト | |
| CN112153897B (zh) | 用于治疗神经病学和其他病症的组合物和方法 | |
| JP4694563B2 (ja) | ヒューマニン受容体又はヒュ−マニン様ポリペプチド受容体 | |
| DK2536747T3 (en) | POLYNUCLEOTIDE USED FOR THE TREATMENT OF INFLUENZA A VIRUS-INDUCED DISEASES AND CODING MODIFIED MX PROTEIN, THE MODIFIED MODIFIED MX PROTEIN, AND A TRANSGENT ANIMATED DRIVE, AS AN EXTENDED ANIMALS, AS AN EXTERNAL DRIVE, AS AN EXTENDED ANIMALS | |
| D’Angelo et al. | Cloning and characterising an unusual perforin from chicken (Gallus gallus) | |
| Bommineni et al. | Hepatic Transcriptomic Landscape of Chicken Reveals Host Responses to Spotty Liver Disease |